Blake A. Rowe

A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain

Julie A. O’Brien, Wei Lemaire, Marion Wittmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2004 · 172 citations

Decreased α-secretase-cleaved amyloid precursor protein as a diagnostic marker for Alzheimer's diseas

Lars Lannfelt, Hans Basun, Lars‐Olof Wahlund et al. · Nature Medicine · 1995 · 170 citations

Neurodegenerative Diseases, Alzheimer's Disease, Biochemistry +10

Pharmacological Characterization and Identification of Amino Acids Involved in the Positive Modulation of Metabotropic Glutamate Receptor Subtype 2

Hervé Schaffhauser, Blake A. Rowe, Sylvia Morales et al. · Molecular Pharmacology · 2003 · 158 citations

[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine Binding to Metabotropic Glutamate Receptor Subtype 5 in Rodent Brain: In Vitro and in Vivo Characterization

Jeffery J. Anderson, Sara Rao, Blake A. Rowe et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 107 citations · Full text

Group II mGlu Receptor Activation Suppresses Norepinephrine Release in the Ventral Hippocampus and Locomotor Responses to Acute Ketamine Challenge

Daniel S. Lorrain, Hervé Schaffhauser, Una C. Campbell et al. · Neuropsychopharmacology · 2003 · 94 citations · Full text

Locomotor Responses, Neurophysiology, Medicine +11